Calidi Biotherapeutics (CLDI) Operating Leases (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Operating Leases of $277000.0 for Q4 2025, down 84.99% year-over-year from $1.8 million in Q4 2024, and down 56.72% quarter-over-quarter from $640000.0 in Q3 2025.
Calidi Biotherapeutics (CLDI) Operating Leases (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' Operating Leases history runs 4 years deep, the most recent figure standing at $277000.0 for Q4 2025.
- In Q4 2025, Operating Leases fell 84.99% year-over-year to $277000.0; the TTM figure through Dec 2025 stood at $277000.0 (down 84.99% YoY), while the FY2025 annual figure was $277000.0, down 84.99% from the prior year.
- Operating Leases for Q4 2025 stood at $277000.0, down from $640000.0 in the prior quarter.
- The five-year high for Operating Leases was $3.8 million in Q1 2023, with the low at $152000.0 in Q3 2022.
- The 4-year median for Operating Leases is $2.0 million (2024), against an average of $1.9 million.
- The sharpest annual moves came in 2023 and 2025: Operating Leases surged 2024.34% in 2023, then sank 84.99% in 2025.
- Calidi Biotherapeutics' Operating Leases stood at $305000.0 in 2022, then jumped by 895.74% to $3.0 million in 2023, then slumped by 39.25% to $1.8 million in 2024, then tumbled by 84.99% to $277000.0 in 2025.
- Business Quant data shows CLDI's Operating Leases at $277000.0 in Q4 2025, $640000.0 in Q3 2025, and $993000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Calidi Biotherapeutics | 1.93 Mn | -2.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Dec 31, 2025 | 277,000.00 |
| Sep 30, 2025 | 640,000.00 |
| Jun 30, 2025 | 993,000.00 |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.76 Mn |
| Dec 31, 2023 | 3.04 Mn |
| Sep 30, 2023 | 3.23 Mn |
| Jun 30, 2023 | 3.55 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 305,000.00 |
| Sep 30, 2022 | 152,000.00 |